Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. | BMC Pediatr | 2021 | 34325699 | PubTator, text mining | PubMed |
| Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer. | PLoS One | 2021 | 34320033 | PubTator, text mining | PubMed |
| Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis. | NAR Cancer | 2021 | 34316701 | PubTator, text mining | PubMed |
| Acute myeloid leukemia arising to genetic susceptibility genes related T cell acute lymphoblastic leukemia: case report. | AME Case Rep | 2021 | 34312608 | PubTator, text mining | PubMed |
| Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. | Nat Cancer | 2021 | 34308366 | PubTator, text mining | PubMed |
| The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma. | Front Oncol | 2021 | 34307148 | PubTator, text mining | PubMed |
| The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families. | Cancers (Basel) | 2021 | 34298626 | PubTator, text mining | PubMed |
| Effect of whole-body vibration therapy on lower extremity function in subacute stroke patients. | J Exerc Rehabil | 2021 | 34285892 | PubTator, text mining | PubMed |
| Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 | 34285390 | PubTator, text mining | PubMed |
| Molecular profiling of basal cell carcinomas in young patients. | BMC Med Genomics | 2021 | 34284772 | PubTator, text mining | PubMed |
| Incidental findings from cancer next generation sequencing panels. | NPJ Genom Med | 2021 | 34282142 | PubTator, text mining | PubMed |
| Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity! | Oncol Rev | 2021 | 34267891 | PubTator, text mining | PubMed |
| Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors. | Urol Case Rep | 2021 | 34258232 | PubTator, text mining | PubMed |
| Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer. | Genet Med | 2021 | 34257420 | PubTator, text mining | PubMed |
| The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access. | World J Emerg Surg | 2021 | 34256781 | PubTator, text mining | PubMed |
| FANCI functions as a repair/apoptosis switch in response to DNA crosslinks. | Dev Cell | 2021 | 34256011 | PubTator, text mining | PubMed |
| A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer. | J Gastroenterol | 2021 | 34255164 | PubTator, text mining | PubMed |
| A computational and structural analysis of germline and somatic variants affecting the DDR mechanism, and their impact on human diseases. | Sci Rep | 2021 | 34253785 | PubTator, text mining | PubMed |
| Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies. | Front Oncol | 2021 | 34249714 | PubTator, text mining | PubMed |
| Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma. | Front Oncol | 2021 | 34249695 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=41